Andrea M. Gross

Cincinnati Children's Hospital Medical Center

Also affiliated with National Institutes of Health, Hospital Research Foundation, National Cancer Center, National Cancer Institute, National Cancer Institute, Center for Cancer Research, National Cancer Research Institute, University of Cincinnati Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Neuro-Oncology(2023)10.1093/neuonc/noad086

N/A

2.3DataRank · unranked

97 citations

Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey R. Herrera +14 more

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Neuro-Oncology(2022)10.1093/neuonc/noac109

N/A

1.7DataRank · unranked

66 citations

Brittany Glassberg, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Michael J. Fisher +18 more

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial

Nature Medicine(2025)10.1038/s41591-024-03361-4

N/A

0.954DataRank · unranked

41 citations

Geraldine O’Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G. Herrick, Staci Martin +30 more

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709

N/A

0.652DataRank · unranked

20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1611

N/A

0.524DataRank · unranked

32 citations

Anirban Das, Sarah Scollon, Sarah G. Mitchell, Mary‐Louise C. Greer, Marielle E. Yohe +22 more

The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review

The Oncologist(2023)10.1093/oncolo/oyad285

N/A

0.522DataRank · unranked

13 citations

Karlyne M. Reilly, Brigitte C. Widemann, Mary Frances Wedekind, Corrie Painter, Allison F. O’Neill +5 more

Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1

Neuro-Oncology(2024)10.1093/neuonc/noae235

N/A

0.520DataRank · unranked

31 citations

Andrea M. Gross, Carlos G. Romo, Carina Dehner, Alexander J. Lazar, Markku Miettinen +60 more

Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors

American Society of Clinical Oncology Educational Book(2024)10.1200/edbk_432242

N/A

0.505DataRank · unranked

28 citations

Carina Dehner, Eva Dombi, Vanessa Eulo, Andrea M. Gross, R. Taylor Sundby +3 more

Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3612

N/A

0.483DataRank · unranked

24 citations

Andrea M. Gross, Eva Dombi, Cecilia Tibery, Amanda Carbonell, Naoko Takebe +13 more

Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0566

N/A

0.475DataRank · unranked

11 citations

Casey L. Kilpatrick, Melinda G. Hollingshead, Dominic Esposito, Geraldine O’Sullivan Coyne, Andrea M. Gross +7 more

Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy

Journal of Pediatric Orthopaedics(2023)10.1097/bpo.0000000000002431

N/A

0.345DataRank · unranked

9 citations

Krishna V. Suresh, Jaime A. Gómez, John B. Emans, A. Noelle Larson, Patrick J. Cahill +18 more

Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series

Pediatric Blood & Cancer(2025)10.1002/pbc.31814

N/A

0.330DataRank · unranked

8 citations

Madeline H. Fitzhugh, Jennifer S. Ko, Allison Close, Sara C. Horton, Faizan Malik +26 more

Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics

medRxiv(2024)10.1101/2024.01.18.24301053

N/A

0.208DataRank · unranked

3 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration

Clinical Trials(2023)10.1177/17407745231201345

N/A

0.165DataRank · unranked

2 citations

Andrea M. Gross, Brigitte C. Widemann, Scott R. Plotkin, Vanessa L. Merker

A Pilot Acceptance and Commitment Intervention for Parents of Children With RASopathies

Clinical Practice in Pediatric Psychology(2024)10.1037/cpp0000551

N/A

0.104DataRank · unranked

1 citations

Nour Al Ghriwati, Atara Siegel, Mary Anne Toledo‐Tamula, Millicent S. Curlee, Melissa Baker +5 more

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1

Clinical Trials(2023)10.1177/17407745231201338

N/A

0DataRank · unranked

1 citations

Scott R. Plotkin, Nelson B. Watts, Michael J. Fisher, Laura J. Klesse, Andrés J Lessing +9 more

Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1

Clinical Trials(2023)10.1177/17407745231206402

N/A

0DataRank · unranked

0 citations

Gurbani Singh, Eva Dombi, Pamela L. Wolters, Staci Martin, Andrea Baldwin +14 more

Audiometric and Otologic Findings in Children and Young Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas

The Laryngoscope(2022)10.1002/lary.30522

N/A

0DataRank · unranked

4 citations

Julie Christensen, Andrea M. Gross, Eva Dombi, Jennifer R Miles, Kelly King +9 more

Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population

Supportive Care in Cancer(2022)10.1007/s00520-022-06818-9

N/A

0DataRank · unranked

7 citations

Jeffrey S. Dome, Jiaxiang Gai, Andrea M. Gross, Elena Postell, Pamela S. Hinds +4 more

Cancer incidence and surveillance strategies in individuals withRASopathies

American Journal of Medical Genetics Part C Seminars in Medical Genetics(2022)10.1002/ajmg.c.32018

N/A

0DataRank · unranked

25 citations

Andrea M. Gross, Alicia A. Livinski, Christian P. Kratz, Douglas R. Stewart, Gina M. Ney

Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0797

N/A

0DataRank · unranked

22 citations

Jeffrey J. Szymanski, Alexander Pan, Paul A. Jones, Sana Mahmood, Olivia H. Reid +24 more

Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT

Future Oncology(2024)10.2217/fon-2023-0565

N/A

0DataRank · unranked

5 citations

Colette Achée, Sarah E. Hart, Lindsay Brewer, Andrea Baldwin, Pamela L. Wolters +3 more

Pharmacogenetic and Clinical Predictors of Ondansetron Failure in a Diverse Pediatric Oncology Population

Research Square(2021)10.21203/rs.3.rs-762220/v1

N/A

0DataRank · unranked

0 citations

Jeffrey S. Dome, Jiaxiang Gai, Andrea M. Gross, Elena Postell, Pamela S. Hinds +4 more

The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa095

N/A

0DataRank · unranked

38 citations

Eva H. Baker, Andrea M. Gross, Patricia Whitcomb, Andrea Baldwin, Joanne Derdak +9 more

Advancing RAS/RASopathy therapies: An NCI‐sponsored intramural and extramural collaboration for the study of RASopathies

American Journal of Medical Genetics Part A(2020)10.1002/ajmg.a.61485

N/A

0DataRank · unranked

63 citations

Megan N. Frone, Karen W. Gripp, Bruce D. Gelb, Lisa Schoyer, Lisa Schill +17 more

Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf201

N/A

0DataRank · unranked

5 citations

Brigitte C. Widemann, Andrea M. Gross, Andrea Baldwin, Said Farschtschi, Victor‐Felix Mautner +2 more

Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy

Ophthalmology(2025)10.1016/j.ophtha.2025.09.031

N/A

0DataRank · unranked

0 citations

Andrea M. Gross, Chantal Cousineau-Krieger, Tiarnán D L Keenan, Taylor McManus, Connor J Dallas +12 more

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561

N/A

0DataRank · unranked

4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more

The prostate is a common site of disease in patients with MEN2B and medullary thyroid carcinoma

Endocrine Related Cancer(2025)10.1530/erc-24-0243

N/A

0DataRank · unranked

0 citations

Srivandana Akshintala, Andrea M. Gross, Eva Dombi, Barış Türkbey, Sandra Bednarova +9 more